Katy Barglow

Chief Technical Officer at 4D Molecular Therapeutics

Walnut Creek, California, United States

About Katy Barglow

Katy Barglow is Chief Technical Officer at 4D Molecular Therapeutics. Location: Walnut Creek, California, United States.

CMC leader in the gene therapy space, leading process development, manufacturing, analytical development, QC/QA, and supply chain functions. I am currently Chief Technology Officer at 4D Molecular Therapeutics, a novel AAV gene therapy company. I am responsible for driving our "IND engine" and CMC strategy (process, analytical, and CMC-quality/regulatory) for pre-clinical through late-phase clinical (soon to be commercial!) AAV products.

Skills

  • Proteomics
  • Mass Spectrometry
  • Protein Chemistry

Additional experience

  • Senior Vice President

    4D Molecular Therapeutics

    January 2022 – January 2026

Education

  • Doctor of Philosophy (PhD), Scripps Research
  • Postdoctoral Fellow, University of California, Berkeley